Advertisement Pharmaceutical Business review - Page 774 of 5281 -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
July 9, 2026

Sino and AstraZeneca sign licence agreement for TQC3721

AstraZeneca and Sino Biopharmaceutical’s subsidiary Chia Tai Tianqing Pharmaceutical Group (CTTQ) have signed an exclusive licence agreement for TQC3721.

The agreement covers certain future development programmes on an exclusive worldwide basis for AstraZeneca. Credit: Jose Eduardo Rubio / Shutterstock.com.